{"id":57922,"date":"2024-02-27T18:07:25","date_gmt":"2024-02-27T18:07:25","guid":{"rendered":"https:\/\/medsname.com\/lefuheal\/"},"modified":"2026-04-30T10:24:19","modified_gmt":"2026-04-30T10:24:19","slug":"lefuheal","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/lefuheal\/","title":{"rendered":"Lefuheal"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Lefuheal?<\/h3>\n<p style=\"margin:0;\"><strong>Lefuheal<\/strong> je peror\u00e1ln\u00ed tableta od Healing Pharma obsahuj\u00edc\u00ed <strong>leflunomid 10 mg a 20 mg<\/strong> \u2014 peror\u00e1ln\u00ed <strong>konven\u010dn\u00ed syntetick\u00fd DMARD<\/strong> (chorobu modifikuj\u00edc\u00ed antirevmatikum), kter\u00fd inhibuje dihydroorot\u00e1t dehydrogen\u00e1zu, \u010d\u00edm\u017e blokuje de-novo synt\u00e9zu pyrimidin\u016f v aktivovan\u00fdch lymfocytech. Pou\u017e\u00edv\u00e1 se p\u0159edev\u0161\u00edm u <strong>st\u0159edn\u011b t\u011b\u017ek\u00e9 a\u017e t\u011b\u017ek\u00e9 revmatoidn\u00ed artritidy<\/strong> a <strong>aktivn\u00ed psoriatick\u00e1 artritida<\/strong>, obvykle po selh\u00e1n\u00ed methotrex\u00e1tu nebo jako alternativa k methotrex\u00e1tu. Standardn\u00ed d\u00e1vka pro dosp\u011bl\u00e9: <strong>20 mg jednou denn\u011b<\/strong> (10 mg jednou denn\u011b p\u0159i intoleranci); n\u011bkte\u0159\u00ed p\u0159edepisovatel\u00e9 pou\u017e\u00edvaj\u00ed nasycovac\u00ed d\u00e1vku 100 mg\/den po dobu 3 dn\u016f, ale to zvy\u0161uje riziko \u010dasn\u00e9 hepatotoxicity a pr\u016fjm\u016f a v rutinn\u00ed praxi se tato praxe st\u00e1le \u010dast\u011bji vynech\u00e1v\u00e1. <strong>N\u00e1stup \u00fa\u010dinku je pomal\u00fd \u2014 4\u20136 t\u00fddn\u016f pro po\u010d\u00e1te\u010dn\u00ed \u00fa\u010dinek, 12\u201324 t\u00fddn\u016f pro pln\u00fd \u00fa\u010dinek.<\/strong> Aktivn\u00ed metabolit l\u00e9ku (teriflunomid) m\u00e1 v\u00fdjime\u010dn\u011b dlouh\u00fd polo\u010das (~14 dn\u016f po jedn\u00e9 d\u00e1vce, mnohem del\u0161\u00ed p\u0159i ust\u00e1len\u00e9m enterohepat\u00e1ln\u00edm ob\u011bhu) \u2014 co\u017e je v\u00fdhoda (jednodenn\u00ed d\u00e1vkov\u00e1n\u00ed, tolerance vynechan\u00e9 d\u00e1vky), ale tak\u00e9 to znamen\u00e1, \u017ee <strong>v\u00fdplach cholestyraminem je povinn\u00fd<\/strong> pro pl\u00e1nov\u00e1n\u00ed t\u011bhotenstv\u00ed, p\u0159i z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed reakci nebo rychl\u00e9m p\u0159echodu na jinou terapii. <strong>T\u011bhotensk\u00e1 kategorie X<\/strong> \u2014 jak \u017eeny, tak mu\u017ei u\u017e\u00edvaj\u00edc\u00ed leflunomid mus\u00ed pou\u017e\u00edvat \u00fa\u010dinnou antikoncepci. <strong>Hepatotoxicita je hlavn\u00edm bezpe\u010dnostn\u00edm rizikem<\/strong>; m\u011bs\u00ed\u010dn\u00ed kontrola jatern\u00edch test\u016f\/krevn\u00edho obrazu\/krevn\u00edho tlaku po dobu 6 m\u011bs\u00edc\u016f, pot\u00e9 \u010dtvrtletn\u011b.<\/p>\n<\/div>\n<p><!-- medsbase-specialist-strip --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u2695 L\u00e9k vy\u017eaduj\u00edc\u00ed odborn\u00fd dohled \u2014 nutn\u00fd klinick\u00fd dohled.<\/strong> Toto je z\u00e1va\u017en\u00fd imunomodula\u010dn\u00ed l\u00e9k se specifick\u00fdmi po\u017eadavky na p\u0159edl\u00e9\u010debn\u00e9 vy\u0161et\u0159en\u00ed, \u010dern\u00fdmi v\u00fdstrahami a povinn\u00fdm laboratorn\u00edm monitorov\u00e1n\u00edm. M\u011bl by b\u00fdt p\u0159edepisov\u00e1n a sledov\u00e1n revmatologem, gastroenterologem, dermatologem nebo jin\u00fdm odborn\u00edkem zku\u0161en\u00fdm s jeho u\u017e\u00edv\u00e1n\u00edm. Ne <strong>ne<\/strong> p\u0159edepisujte si ho sami, neupravujte d\u00e1vku ani neza\u010d\u00ednejte\/nep\u0159est\u00e1vejte bez pokyn\u016f p\u0159edepisuj\u00edc\u00edho l\u00e9ka\u0159e. V\u017edy poskytn\u011bte sv\u00e9mu o\u0161et\u0159uj\u00edc\u00edmu l\u00e9ka\u0159i aktu\u00e1ln\u00ed p\u0159edpis p\u0159ed objedn\u00e1n\u00edm z MedsBase.<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f6f8;border:1px solid #e1e4e8;border-radius:4px;padding:14px 18px;margin:18px 0;display:flex;flex-wrap:wrap;gap:14px;font-size:0.95em;\"><span>\u2705 <strong>WHO-GMP certifikov\u00e1no<\/strong> v\u00fdrobce<\/span><span>\ud83d\udce6 <strong>Diskr\u00e9tn\u00ed balen\u00ed<\/strong><\/span><span>\ud83c\udf0d <strong>Dod\u00e1n\u00ed po cel\u00e9m sv\u011bt\u011b<\/strong><\/span><span>\ud83d\udcac <a href=\"\/cs\/reviews\/\">1,400+ recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/span><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Lefuheal?<\/h2>\n<p>Lefuheal jsou peror\u00e1ln\u00ed tablety vyr\u00e1b\u011bn\u00e9 spole\u010dnost\u00ed Healing Pharma obsahuj\u00edc\u00ed <strong>leflunomid<\/strong> \u2014 konven\u010dn\u00ed syntetick\u00fd chorobu modifikuj\u00edc\u00ed antirevmatikum (DMARD). Leflunomid s\u00e1m je prol\u00e9\u010divo, kter\u00e9 se rychle p\u0159em\u011b\u0148uje ve st\u0159ev\u011b a j\u00e1trech na sv\u016fj aktivn\u00ed metabolit <strong>teriflunomid<\/strong> (tak\u00e9 prod\u00e1van\u00fd jako samostatn\u00fd l\u00e9k pro roztrou\u0161enou skler\u00f3zu pod obchodn\u00edm n\u00e1zvem Aubagio).<\/p>\n<p>Lefuheal je generikum leflunomidu zna\u010dky Healing Pharma \u2014 dostupn\u00e9 v sil\u00e1ch 10 mg a 20 mg pro flexibiln\u00ed titraci d\u00e1vky. Tableta 20 mg je standardn\u00ed udr\u017eovac\u00ed d\u00e1vka; tableta 10 mg se pou\u017e\u00edv\u00e1 pro sn\u00ed\u017een\u00ed d\u00e1vky u pacient\u016f s intoleranc\u00ed (zejm\u00e9na pr\u016fjmem, \u0159\u00eddnut\u00edm vlas\u016f nebo m\u00edrn\u00fdm vzestupem ALT) a u star\u0161\u00edch pacient\u016f nebo pacient\u016f s n\u00edzkou t\u011blesnou hmotnost\u00ed. Leflunomid se v rutinn\u00ed revmatologick\u00e9 praxi pou\u017e\u00edv\u00e1 od konce 90. let 20. stolet\u00ed; pat\u0159\u00ed mezi n\u011bkolik peror\u00e1ln\u00edch DMARDs s prok\u00e1zanou rovnocennou \u00fa\u010dinnost\u00ed jako methotrex\u00e1t u revmatoidn\u00ed artritidy. Pou\u017e\u00edv\u00e1 se bu\u010f spolu s methotrex\u00e1tem u rezistentn\u00edho onemocn\u011bn\u00ed, nebo jako hlavn\u00ed DMARD, kdy\u017e methotrex\u00e1t nen\u00ed tolerov\u00e1n.<\/p>\n<h2 class=\"wp-block-heading\">Jak Lefuheal funguje?<\/h2>\n<p>Aktivn\u00ed metabolit teriflunomid selektivn\u011b inhibuje <strong>dihydroorot\u00e1t dehydrogen\u00e1zu (DHODH)<\/strong>, mitochondri\u00e1ln\u00ed enzym kl\u00ed\u010dov\u00fd pro <strong>de-novo synt\u00e9zu pyrimidin\u016f<\/strong>. Aktivovan\u00e9, rychle se d\u011bl\u00edc\u00ed lymfocyty jsou t\u00e9m\u011b\u0159 v\u00fdhradn\u011b z\u00e1visl\u00e9 na t\u00e9to de-novo dr\u00e1ze pro nukleotidy pot\u0159ebn\u00e9 k proliferaci; klidov\u00e9 a pomalu se d\u011bl\u00edc\u00ed bu\u0148ky mohou obej\u00edt DHODH pomoc\u00ed z\u00e1chrann\u00e9 dr\u00e1hy.<\/p>\n<p>V\u00fdsledkem je selektivn\u00ed brzda proliferace aktivovan\u00fdch T-bun\u011bk a B-bun\u011bk:<\/p>\n<ul>\n<li><strong>Sn\u00ed\u017een\u00e1 expanze T-bun\u011bk<\/strong> v zan\u00edcen\u00fdch kloubech a synovi\u00e1ln\u00ed membr\u00e1n\u011b<\/li>\n<li><strong>Sn\u00ed\u017een\u00e1 proliferace B-bun\u011bk<\/strong> a produkce autoprotil\u00e1tek<\/li>\n<li><strong>Sn\u00ed\u017een\u00e1 produkce cytokin\u016f<\/strong> (IL-2, IFN-\u03b3, TNF-\u03b1) aktivovan\u00fdmi lymfocyty<\/li>\n<li><strong>N\u011bkter\u00e9 dal\u0161\u00ed protiz\u00e1n\u011btliv\u00e9 a matrix-ochrann\u00e9 \u00fa\u010dinky<\/strong> v kloubn\u00ed synovi\u00e1ln\u00ed tk\u00e1ni nez\u00e1visl\u00e9 na synt\u00e9ze pyrimidin\u016f<\/li>\n<\/ul>\n<p><strong>Farmakokinetick\u00e9 vlastnosti s klinick\u00fdm v\u00fdznamem:<\/strong><\/p>\n<ul>\n<li><strong>Aktivn\u00ed metabolit teriflunomid m\u00e1 polo\u010das ~14 dn\u00ed<\/strong> po jedn\u00e9 d\u00e1vce. P\u0159i stabiln\u00edm d\u00e1vkov\u00e1n\u00ed a enterohepat\u00e1ln\u00ed recirkulaci m\u016f\u017ee b\u00fdt efektivn\u00ed polo\u010das mnohem del\u0161\u00ed \u2014 co\u017e znamen\u00e1, \u017ee l\u00e9k z\u016fst\u00e1v\u00e1 m\u011b\u0159iteln\u00fd v plazm\u011b m\u011bs\u00edce po vysazen\u00ed.<\/li>\n<li><strong>Proto je nutn\u00e1 v\u00fdplachov\u00e1 terapie cholestyraminem<\/strong> (8 g t\u0159ikr\u00e1t denn\u011b po dobu 11 dn\u016f), pokud je vy\u017eadov\u00e1na rychl\u00e1 eliminace l\u00e9ku \u2014 p\u0159i pl\u00e1nov\u00e1n\u00ed t\u011bhotenstv\u00ed, z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed reakci nebo rychl\u00e9m p\u0159echodu na jinou terapii.<\/li>\n<li><strong>N\u00e1stup klinick\u00e9ho \u00fa\u010dinku je pomal\u00fd<\/strong>: 4\u20136 t\u00fddn\u016f pro prvn\u00ed zn\u00e1mky zlep\u0161en\u00ed, 12\u201324 t\u00fddn\u016f pro pln\u00fd efekt. Pacienti \u010dasto cht\u011bj\u00ed l\u00e9\u010dbu p\u0159ed\u010dasn\u011b ukon\u010dit; pomal\u00fd pr\u016fb\u011bh mus\u00ed b\u00fdt stanoven jako o\u010dek\u00e1v\u00e1n\u00ed od za\u010d\u00e1tku.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>St\u0159edn\u011b t\u011b\u017ek\u00e1 a\u017e t\u011b\u017ek\u00e1 revmatoidn\u00ed artritida<\/strong> \u2014 hlavn\u00ed indikace. Pou\u017e\u00edv\u00e1 se jako monoterapie, kdy\u017e nen\u00ed tolerov\u00e1n methotrex\u00e1t, nebo v kombinaci s methotrex\u00e1tem u rezistentn\u00edho onemocn\u011bn\u00ed.<\/li>\n<li><strong>Aktivn\u00ed psoriatick\u00e9 artritidy<\/strong> \u2014 zejm\u00e9na u perifern\u00edho posti\u017een\u00ed kloub\u016f; m\u00e9n\u011b \u00fa\u010dinn\u00e9 pro axi\u00e1ln\u00ed onemocn\u011bn\u00ed.<\/li>\n<li><strong>Mimo indikaci: z\u00e1va\u017en\u00e9 z\u00e1n\u011btliv\u00e9 a autoimunitn\u00ed stavy<\/strong> \u2014 lupusov\u00e1 artritida, Feltyho syndrom, sarkoid\u00f3za, t\u011b\u017ek\u00e9 pyoderma gangrenosum, udr\u017eovac\u00ed l\u00e9\u010dba ANCA-asociovan\u00e9 vaskulitidy, juveniln\u00ed idiopatick\u00e1 artritida.<\/li>\n<li><strong>Mimo indikaci: nefropatie zp\u016fsoben\u00e1 virem BK po transplantaci ledvin<\/strong> \u2014 vyu\u017e\u00edv\u00e1 antivirov\u00fd \u00fa\u010dinek inhibice pyrimidin\u016f.<\/li>\n<\/ul>\n<p>Lefuheal je <strong>ne<\/strong> vhodn\u00fd pro: ankylozuj\u00edc\u00ed spondylitidu (bez prosp\u011bchu pro axi\u00e1ln\u00ed posti\u017een\u00ed), m\u00edrnou revmatoidn\u00ed artritidu (nejprve sulfasalazin nebo hydroxychlorochin), kr\u00e1tkodobou \u00falevu od p\u0159\u00edznak\u016f (l\u00e9k za\u010d\u00edn\u00e1 p\u016fsobit a\u017e po t\u00fddnech) nebo pacienty, kte\u0159\u00ed nemohou podstoupit m\u011bs\u00ed\u010dn\u00ed krevn\u00ed testy po dobu alespo\u0148 6 m\u011bs\u00edc\u016f.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed p\u0159\u00edpravku Lefuheal a zp\u016fsob u\u017e\u00edv\u00e1n\u00ed<\/h2>\n<p>Lefuheal je dod\u00e1v\u00e1n v <strong>d\u00e1vk\u00e1ch 10 mg a 20 mg<\/strong>. Standardn\u00ed d\u00e1vkov\u00e1n\u00ed pro dosp\u011bl\u00e9 je p\u0159\u00edmo\u010dar\u00e9, ale vy\u017eaduje pe\u010dliv\u00e9 pl\u00e1nov\u00e1n\u00ed ohledn\u011b antikoncepce a z\u00e1kladn\u00edho monitorov\u00e1n\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Mo\u017enosti d\u00e1vkov\u00e1n\u00ed<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">P\u0159\u00edstup<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Re\u017eim<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kompromis<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Nasycovac\u00ed d\u00e1vka (tradi\u010dn\u00ed)<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">100 mg jednou denn\u011b po dobu 3 dn\u016f, pot\u00e9 20 mg jednou denn\u011b<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Rychlej\u0161\u00ed dosa\u017een\u00ed ust\u00e1len\u00e9ho stavu p\u0159ibli\u017en\u011b o 2 t\u00fddny, ale vy\u0161\u0161\u00ed v\u00fdskyt \u010dasn\u00e9ho pr\u016fjmu, hepatotoxicity a p\u0159eru\u0161en\u00ed l\u00e9\u010dby<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Bez \u00favodn\u00edho nasycen\u00ed (preferov\u00e1no v modern\u00ed praxi)<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">10\u201320 mg jednou denn\u011b od prvn\u00edho dne<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pomalej\u0161\u00ed dosa\u017een\u00ed ust\u00e1len\u00e9ho stavu; lep\u0161\u00ed sn\u00e1\u0161enlivost; ni\u017e\u0161\u00ed m\u00edra p\u0159eru\u0161en\u00ed l\u00e9\u010dby. Ust\u00e1len\u00fd stav dosa\u017een za 8\u201312 t\u00fddn\u016f.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Sn\u00ed\u017een\u00e1 d\u00e1vka pro lep\u0161\u00ed sn\u00e1\u0161enlivost<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">10 mg jednou denn\u011b dlouhodob\u011b<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">U\u017eite\u010dn\u00e9, kdy\u017e 20 mg\/den zp\u016fsobuje nesnesiteln\u00fd pr\u016fjem; \u010d\u00e1ste\u010dn\u00e1 ztr\u00e1ta \u00fa\u010dinnosti<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Kombinace s methotrex\u00e1tem<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">10\u201320 mg leflunomidu + standardn\u00ed d\u00e1vka methotrex\u00e1tu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vy\u0161\u0161\u00ed \u00fa\u010dinnost, ale zv\u00fd\u0161en\u00e9 riziko hepatotoxicity a infekc\u00ed; vy\u017eaduje bli\u017e\u0161\u00ed monitorov\u00e1n\u00ed<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b u\u017e\u00edvat Lefuheal<\/h3>\n<ol>\n<li><strong>U\u017e\u00edvejte stejnou d\u00e1vku ve stejnou dobu jednou denn\u011b<\/strong>, s j\u00eddlem nebo nala\u010dno \u2013 strava m\u00e1 minim\u00e1ln\u00ed vliv na vst\u0159eb\u00e1v\u00e1n\u00ed.<\/li>\n<li><strong>Tabletu spolkn\u011bte celou a zapijte vodou.<\/strong> Nedr\u0165te a nerozd\u011blujte.<\/li>\n<li><strong>Nezahajujte l\u00e9\u010dbu bez z\u00e1kladn\u00edho pl\u00e1nu<\/strong> \u2013 z\u00e1kladn\u00ed vy\u0161et\u0159en\u00ed jatern\u00edch funkc\u00ed (LFT), krevn\u00edho obrazu (CBC), krevn\u00edho tlaku (BP), t\u011bhotensk\u00fd test (u \u017een v plodn\u00e9m v\u011bku), potvrzen\u00ed \u00fa\u010dinn\u00e9 antikoncepce u OBOU partner\u016f, screening na latentn\u00ed TBC a chronick\u00e9 virov\u00e9 hepatitidy, pokud je indikov\u00e1n.<\/li>\n<li><strong>Prov\u00e1d\u011bjte m\u011bs\u00ed\u010dn\u00ed kontrolu LFT, CBC a BP<\/strong> po prvn\u00edch 6 m\u011bs\u00edc\u016f, pot\u00e9 \u010dtvrtletn\u011b dlouhodob\u011b. <strong>Toto nen\u00ed p\u0159edm\u011btem diskuse.<\/strong> Jak\u00e9koli zv\u00fd\u0161en\u00ed ALT nebo AST nad 2\u20133\u00d7 horn\u00ed hranice norm\u00e1lu mus\u00ed vyvolat p\u0159ezkoum\u00e1n\u00ed l\u00e9ka\u0159em a obvykle sn\u00ed\u017een\u00ed d\u00e1vky nebo p\u0159eru\u0161en\u00ed l\u00e9\u010dby.<\/li>\n<li><strong>\u00da\u010dinn\u00e1 antikoncepce je povinn\u00e1<\/strong> u \u017een v plodn\u00e9m v\u011bku po celou dobu l\u00e9\u010dby A alespo\u0148 2 roky po jej\u00edm ukon\u010den\u00ed (nebo dokud v\u00fdplach cholestyraminem nepotvrd\u00ed hladinu teriflunomidu v plazm\u011b &lt; 0,02 mg\/l ve dvou samostatn\u00fdch vzorc\u00edch v intervalu 14 dn\u016f). <strong>Mu\u017e\u0161t\u00ed partne\u0159i<\/strong> u\u017e\u00edvaj\u00edc\u00ed leflunomid, jejich\u017e partnerka by mohla ot\u011bhotn\u011bt, by m\u011bli tak\u00e9 pou\u017e\u00edvat bari\u00e9rovou antikoncepci \u2013 teriflunomid je detekovateln\u00fd v semeni.<\/li>\n<li><strong>Vyhn\u011bte se \u017eiv\u00fdm vakc\u00edn\u00e1m<\/strong> b\u011bhem terapie. Inaktivovan\u00e9 vakc\u00edny (ka\u017edoro\u010dn\u00ed ch\u0159ipka, pneumokokov\u00e1, COVID-19, rekombinantn\u00ed Shingrix) jsou v po\u0159\u00e1dku a doporu\u010duj\u00ed se; ide\u00e1ln\u011b podan\u00e9 p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby.<\/li>\n<li><strong>Informujte ka\u017ed\u00e9ho zdravotnick\u00e9ho pracovn\u00edka, \u017ee u\u017e\u00edv\u00e1te Lefuheal<\/strong> \u2014 zejm\u00e9na p\u0159ed nov\u00fdm p\u0159edpisem, operac\u00ed nebo pl\u00e1nov\u00e1n\u00edm t\u011bhotenstv\u00ed.<\/li>\n<li><strong>Vyhn\u011bte se hepatotoxick\u00fdm l\u00e9k\u016fm a omezte alkohol<\/strong> \u2014 v kombinaci s methotrex\u00e1tem nebo alkoholem se hepatotoxicita leflunomidu v\u00fdrazn\u011b zvy\u0161uje. V\u011bt\u0161ina revmatolog\u016f doporu\u010duje maxim\u00e1ln\u011b 1\u20132 alkoholov\u00e9 jednotky t\u00fddn\u011b.<\/li>\n<li><strong>Bu\u010fte trp\u011bliv\u00ed<\/strong> \u2014 prvn\u00ed zn\u00e1mky \u00fa\u010dinku se objevuj\u00ed za 4\u20136 t\u00fddn\u016f; pln\u00fd efekt za 12\u201324 t\u00fddn\u016f. Nep\u0159est\u00e1vejte u\u017e\u00edvat l\u00e9k po 4 t\u00fddnech, proto\u017ee \u201cnefunguje\u201d.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Cholestyraminov\u00fd v\u00fdplach \u2014 pro\u010d a kdy<\/h2>\n<p>Aktivn\u00ed metabolit teriflunomid proch\u00e1z\u00ed <strong>enterohepat\u00e1ln\u00ed recirkulac\u00ed<\/strong>: vylu\u010duje se do \u017elu\u010di, vst\u0159eb\u00e1v\u00e1 se ve st\u0159ev\u011b a vrac\u00ed se do krevn\u00edho ob\u011bhu. Proto z\u016fst\u00e1v\u00e1 teriflunomid m\u011b\u0159iteln\u00fd v plazm\u011b po mnoho m\u011bs\u00edc\u016f po vysazen\u00ed leflunomidu a proto je nutn\u00fd speci\u00e1ln\u00ed v\u00fdplach, kdy\u017e je vy\u017eadov\u00e1no rychl\u00e9 odstran\u011bn\u00ed.<\/p>\n<p><strong>Cholestyramin<\/strong> (or\u00e1ln\u00ed sekvestrant \u017elu\u010dov\u00fdch kyselin) v\u00e1\u017ee teriflunomid ve st\u0159ev\u011b, \u010d\u00edm\u017e p\u0159eru\u0161uje enterohepat\u00e1ln\u00ed cyklus a v\u00fdrazn\u011b urychluje eliminaci.<\/p>\n<p><strong>Standardn\u00ed protokol v\u00fdplachu:<\/strong><\/p>\n<ul>\n<li><strong>Cholestyramin 8 g t\u0159ikr\u00e1t denn\u011b po dobu 11 dn\u016f<\/strong> (alternativa: aktivn\u00ed uhl\u00ed 50 g \u010dty\u0159ikr\u00e1t denn\u011b po dobu 11 dn\u016f)<\/li>\n<li><strong>Pot\u00e9 zkontrolujte hladinu teriflunomidu v plazm\u011b<\/strong> \u2014 m\u011bla by b\u00fdt &lt; 0,02 mg\/l<\/li>\n<li><strong>Ov\u011b\u0159te na druh\u00e9m samostatn\u00e9m vzorku odebran\u00e9m nejm\u00e9n\u011b 14 dn\u00ed pozd\u011bji<\/strong> pro potvrzen\u00ed trval\u00e9ho vym\u00fdcen\u00ed<\/li>\n<li>T\u011bhotenstv\u00ed lze bezpe\u010dn\u011b pl\u00e1novat a\u017e pot\u00e9, co oba vzorky jsou pod prahovou hodnotou<\/li>\n<\/ul>\n<p><strong>Kdy pou\u017e\u00edt protokol pro vym\u00fdcen\u00ed:<\/strong><\/p>\n<ul>\n<li>Pl\u00e1novan\u00e9 t\u011bhotenstv\u00ed u pacientky (bez ohledu na to, jak ned\u00e1vno bylo leflunomid vysazen)<\/li>\n<li>Nepl\u00e1novan\u00e9 t\u011bhotenstv\u00ed p\u0159i u\u017e\u00edv\u00e1n\u00ed leflunomidu \u2014 okam\u017eit\u00e1 aplikace cholestyraminu a konzultace s gynekologem<\/li>\n<li>Z\u00e1va\u017en\u00e1 ne\u017e\u00e1douc\u00ed reakce (t\u011b\u017ek\u00e1 hepatotoxicita, t\u011b\u017ek\u00e1 vyr\u00e1\u017eka, t\u011b\u017ek\u00e1 cytopenie, t\u011b\u017ek\u00e1 interstici\u00e1ln\u00ed plicn\u00ed nemoc)<\/li>\n<li>Rychl\u00fd p\u0159echod na biologickou l\u00e9\u010dbu nebo jin\u00fd DMARD, kde by sou\u010dasn\u00e1 p\u0159\u00edtomnost teriflunomidu zv\u00fd\u0161ila riziko<\/li>\n<li>Akutn\u00ed p\u0159ed\u00e1vkov\u00e1n\u00ed<\/li>\n<\/ul>\n<p>Bez vyplaven\u00ed m\u016f\u017ee teriflunomid p\u0159etrv\u00e1vat v plazm\u011b a\u017e 2 roky.<\/p>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky Lefuhealu<\/h2>\n<p>Leflunomid je obecn\u011b sn\u00e1\u0161en podobn\u011b jako methotrex\u00e1t \u2014 p\u0159ibli\u017en\u011b 1 z 5 pacient\u016f l\u00e9k vysad\u00ed b\u011bhem prvn\u00edho roku kv\u016fli vedlej\u0161\u00edm \u00fa\u010dink\u016fm.<\/p>\n<p><strong>\u010cast\u00e9 (&gt; 10 %):<\/strong><\/p>\n<ul>\n<li><strong>Pr\u016fjem<\/strong> \u2014 17\u201325 % pacient\u016f; obvykle za\u010d\u00edn\u00e1 v prvn\u00edch 2\u20133 m\u011bs\u00edc\u00edch; \u010dasto se zlep\u0161\u00ed sn\u00ed\u017een\u00edm d\u00e1vky na 10 mg\/den nebo do\u010dasn\u00fdm pod\u00e1n\u00edm cholestyraminu<\/li>\n<li><strong>\u0158\u00eddnut\u00ed vlas\u016f, alopecie<\/strong> \u2014 10\u201320 %; obvykle m\u00edrn\u00e9; reverzibiln\u00ed po vysazen\u00ed<\/li>\n<li><strong>Nevolnost, bolesti b\u0159icha<\/strong><\/li>\n<li><strong>Hypertenze<\/strong> \u2014 10 %; \u0159e\u0161it standardn\u00edm zp\u016fsobem<\/li>\n<li><strong>M\u00edrn\u00e9 zv\u00fd\u0161en\u00ed ALT\/AST<\/strong> \u2014 b\u011b\u017en\u00e9; obvykle se uprav\u00ed nebo reaguje na sn\u00ed\u017een\u00ed d\u00e1vky<\/li>\n<li><strong>Bolest hlavy<\/strong><\/li>\n<li><strong>Ko\u017en\u00ed vyr\u00e1\u017eka<\/strong> \u2014 m\u00edrn\u00e9; z\u0159\u00eddka z\u00e1va\u017en\u00e9<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9 a\u017e vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Z\u00e1va\u017en\u00e1 hepatotoxicita<\/strong> \u2014 vz\u00e1cn\u00e9, ale byly hl\u00e1\u0161eny \u00famrt\u00ed; nejvy\u0161\u0161\u00ed riziko v prvn\u00edch 6 m\u011bs\u00edc\u00edch. Vy\u0161\u0161\u00ed p\u0159i kombinaci s methotrex\u00e1tem nebo konzumac\u00ed alkoholu.<\/li>\n<li><strong>Pancytopenie, agranulocyt\u00f3za, t\u011b\u017ek\u00e1 trombocytopenie<\/strong><\/li>\n<li><strong>Interstici\u00e1ln\u00ed plicn\u00ed onemocn\u011bn\u00ed<\/strong> \u2014 nov\u011b vznikl\u00e1 du\u0161nost nebo neproduktivn\u00ed ka\u0161el b\u011bhem l\u00e9\u010dby mus\u00ed b\u00fdt vy\u0161et\u0159ena; riziko je nejvy\u0161\u0161\u00ed u pacient\u016f s p\u0159edchoz\u00ed interstici\u00e1ln\u00ed plicn\u00ed nemoc\u00ed nebo plicn\u00edm onemocn\u011bn\u00edm.<\/li>\n<li><strong>Z\u00e1va\u017en\u00e9 ko\u017en\u00ed reakce<\/strong> (Stevens-Johnson\u016fv syndrom, toxick\u00e1 epiderm\u00e1ln\u00ed nekrol\u00fdza, DRESS)<\/li>\n<li><strong>T\u011b\u017ek\u00e1 infekce<\/strong> (reaktivace TBC, oportunn\u00ed pl\u00eds\u0148ov\u00e9 infekce, t\u011b\u017ek\u00e9 varicelly, Pneumocystis)<\/li>\n<li><strong>Perifern\u00ed neuropatie<\/strong> \u2014 obvykle reverzibiln\u00ed po vysazen\u00ed (s v\u00fdplachem cholestyraminem)<\/li>\n<li><strong>Hypertenzn\u00ed krize<\/strong> \u2014 vz\u00e1cn\u00e9; \u0159e\u0161it standardn\u00edm postupem<\/li>\n<li><strong>Lymfom<\/strong> \u2014 mal\u00fd absolutn\u00ed n\u00e1r\u016fst, paraleln\u011b s jin\u00fdmi imunosupresivy<\/li>\n<\/ul>\n<p><strong>T\u011bhotenstv\u00ed a plodnost:<\/strong><\/p>\n<ul>\n<li><strong>Siln\u011b teratogenn\u00ed v anim\u00e1ln\u00edch modelech<\/strong> \u2014 embryolet\u00e1ln\u00ed a teratogenn\u00ed u potkan\u016f a kr\u00e1l\u00edk\u016f v d\u00e1vk\u00e1ch ekvivalentn\u00edch lidsk\u00fdm<\/li>\n<li>Teratogenita u lid\u00ed je m\u00e9n\u011b jasn\u011b prok\u00e1z\u00e1na, ale plat\u00ed princip p\u0159edb\u011b\u017en\u00e9 opatrnosti \u2014 hodnoceno <strong>T\u011bhotensk\u00e1 kategorie X<\/strong><\/li>\n<li>OB\u011a pohlav\u00ed mus\u00ed pou\u017e\u00edvat \u00fa\u010dinnou antikoncepci b\u011bhem terapie<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>P\u0159edchoz\u00ed jatern\u00ed po\u0161kozen\u00ed<\/strong> \u2014 absolutn\u00ed kontraindikace u st\u0159edn\u011b t\u011b\u017ek\u00e9ho a\u017e t\u011b\u017ek\u00e9ho onemocn\u011bn\u00ed; relativn\u00ed u lehk\u00e9ho onemocn\u011bn\u00ed.<\/li>\n<li><strong>Aktivn\u00ed nebo nel\u00e9\u010den\u00e1 infekce<\/strong> \u2014 odlo\u017ete a\u017e do vy\u0159e\u0161en\u00ed.<\/li>\n<li><strong>Latentn\u00ed TBC, hepatitida B\/C<\/strong> \u2014 vy\u0161et\u0159en\u00ed p\u0159ed zah\u00e1jen\u00edm; pova\u017eujte za vhodn\u00e9.<\/li>\n<li><strong>Hypertenze<\/strong> \u2014 kontrolujte p\u0159ed zah\u00e1jen\u00edm; sledujte TK m\u011bs\u00ed\u010dn\u011b b\u011bhem prvn\u00edch 6 m\u011bs\u00edc\u016f.<\/li>\n<li><strong>T\u011b\u017ek\u00e1 imunodeficience<\/strong> \u2014 absolutn\u00ed kontraindikace.<\/li>\n<li><strong>Zna\u010dn\u00e1 hypoprotein\u00e9mie<\/strong> \u2014 \u00fa\u010dinn\u00e1 antikoncepce b\u011bhem l\u00e9\u010dby a po jej\u00edm ukon\u010den\u00ed.<\/li>\n<li><strong>T\u011bhotenstv\u00ed<\/strong> \u2014 <strong>kontraindikov\u00e1no.<\/strong> Teriflunomid je vysoce v\u00e1z\u00e1n na b\u00edlkoviny; n\u00edzk\u00fd albumin zp\u016fsobuje nep\u0159edv\u00eddateln\u00e9 hladiny voln\u00e9ho l\u00e9\u010diva. Pou\u017e\u00edvejte opatrn\u011b.<\/li>\n<li><strong>Kojen\u00ed<\/strong> \u2014 kontraindikace; teriflunomid p\u0159ech\u00e1z\u00ed do ml\u00e9ka.<\/li>\n<li><strong>D\u011bti<\/strong> \u2014 nen\u00ed schv\u00e1len pro obecn\u00e9 pediatrick\u00e9 pou\u017eit\u00ed, i kdy\u017e n\u011bkdy pou\u017e\u00edv\u00e1n pro juveniln\u00ed idiopatickou artritidu pod odborn\u00fdm dohledem.<\/li>\n<li><strong>Star\u0161\u00ed pacienti<\/strong> \u2014 nen\u00ed nutn\u00e1 specifick\u00e1 \u00faprava d\u00e1vkov\u00e1n\u00ed, ale vy\u0161\u0161\u00ed n\u00e1chylnost k gastrointestin\u00e1ln\u00edm ne\u017e\u00e1douc\u00edm \u00fa\u010dink\u016fm, infekc\u00edm a hepatotoxicit\u011b.<\/li>\n<li><strong>\u017div\u00e9 vakc\u00edny<\/strong> \u2014 kontraindikov\u00e1no b\u011bhem terapie a po dobu 2 let po ukon\u010den\u00ed (nebo dokud nen\u00ed potvrzeno vylou\u010den\u00ed). Napl\u00e1nujte v\u0161echna \u017eiv\u00e9 vakc\u00edny P\u0158ED zah\u00e1jen\u00edm l\u00e9\u010dby.<\/li>\n<li><strong>Chirurgie<\/strong> \u2014 u v\u011bt\u0161iny pacient\u016f nen\u00ed nutn\u00e9 vysazovat leflunomid p\u0159ed pl\u00e1novanou operac\u00ed; kr\u00e1tk\u00e9 perioperativn\u00ed vysazen\u00ed je ne\u00fa\u010dinn\u00e9 kv\u016fli dlouh\u00e9mu polo\u010dasu. Proberte s revmatologem.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace \u2013 Kdo by NEM\u011aL u\u017e\u00edvat Lefuheal<\/h2>\n<ul>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na leflunomid nebo teriflunomid<\/li>\n<li>St\u0159edn\u011b t\u011b\u017ek\u00e9 nebo t\u011b\u017ek\u00e9 po\u0161kozen\u00ed jater (Child-Pugh B nebo C)<\/li>\n<li>T\u011b\u017ek\u00e1 imunodeficience (HIV\/AIDS, vrozen\u00e1 imunodeficience, t\u011b\u017ek\u00e1 kombinovan\u00e1 imunodeficience)<\/li>\n<li>T\u011b\u017ek\u00e1 nel\u00e9\u010den\u00e1 infekce<\/li>\n<li>V\u00fdznamn\u00e1 preexistuj\u00edc\u00ed \u00fatlum kostn\u00ed d\u0159en\u011b<\/li>\n<li>T\u011b\u017ek\u00e1 hypoprotein\u00e9mie (t\u011b\u017ek\u00fd nefrotick\u00fd syndrom)<\/li>\n<li>T\u011bhotenstv\u00ed nebo kojen\u00ed<\/li>\n<li>Reproduk\u010dn\u00ed potenci\u00e1l bez \u00fa\u010dinn\u00e9 antikoncepce<\/li>\n<li>Ned\u00e1vn\u00e9 pod\u00e1n\u00ed \u017eiv\u00e9 vakc\u00edny nebo pl\u00e1novan\u00e9 pod\u00e1n\u00ed \u017eiv\u00e9 vakc\u00edny v n\u00e1sleduj\u00edc\u00edch 3 m\u011bs\u00edc\u00edch<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Kombinujte s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Methotrex\u00e1t<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Synergie v kontrole onemocn\u011bn\u00ed A z\u00e1rove\u0148 aditivn\u00ed hepatotoxicita \/ cytopenie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u010cast\u00e1 kombinace; zes\u00edlen\u00e9 monitorov\u00e1n\u00ed (jatern\u00ed testy\/KRK ka\u017ed\u00e9 2 t\u00fddny \u00d7 8, pot\u00e9 m\u011bs\u00ed\u010dn\u011b).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Jin\u00e9 hepatotoxick\u00e9 l\u00e9ky<\/strong> (paracetamol ve vysok\u00fdch d\u00e1vk\u00e1ch, alkohol, isoniazid, ketokonazol, antiepileptika)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinovan\u00e1 hepatotoxicita<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pou\u017e\u00edvejte nejni\u017e\u0161\u00ed \u00fa\u010dinn\u00e9 d\u00e1vky, \u010dast\u011bji monitorujte jatern\u00ed testy, omezte alkohol na \u2264 1\u20132 jednotky\/t\u00fdden.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Warfarin<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prom\u011bnliv\u00fd vzestup INR (mechanismus nejasn\u00fd)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zkontrolujte INR do 1\u20132 t\u00fddn\u016f po zah\u00e1jen\u00ed nebo ukon\u010den\u00ed l\u00e9\u010dby leflunomidem; upravte warfarin podle pot\u0159eby.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Rifampicin<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zvy\u0161uje hladiny teriflunomidu (kontraintuitivn\u00ed; nikoli indukc\u00ed CYP3A4)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pou\u017e\u00edvejte opatrn\u011b; zva\u017ete ni\u017e\u0161\u00ed d\u00e1vku leflunomidu.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Cholestyramin, aktivn\u00ed uhl\u00ed<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">V\u00fdrazn\u011b sni\u017euje hladiny teriflunomidu \u2013 z\u00e1klad protokolu pro vyplaven\u00ed<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se spole\u010dn\u00e9mu pod\u00e1v\u00e1n\u00ed, pokud nen\u00ed c\u00edlem vyplaven\u00ed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>\u017div\u00e9 vakc\u00edny<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Riziko diseminovan\u00e9 infekce vakcina\u010dn\u00edm kmenem<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kontraindikov\u00e1no. Pou\u017eijte inaktivovan\u00e9 alternativy.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Ostatn\u00ed DMARDs a biologika (inhibitory TNF, inhibitory JAK, abatacept, rituximab)<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aditivn\u00ed imunosuprese a riziko infekce<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Specializovan\u00e1 kombinovan\u00e1 terapie; zva\u017ete profylaxi PCP a antivirotiky.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Substr\u00e1ty OAT3 (cefaclor, ciprofloxacin, indomethacin, ketoprofen)<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Teriflunomid m\u016f\u017ee zv\u00fd\u0161it jejich plazmatick\u00e9 hladiny.<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sledujte ne\u017e\u00e1douc\u00ed \u00fa\u010dinky partnersk\u00e9ho l\u00e9ku.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Repaglinid a dal\u0161\u00ed substr\u00e1ty CYP2C8<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Teriflunomid zvy\u0161uje hladiny substr\u00e1t\u016f CYP2C8<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sledujte ne\u017e\u00e1douc\u00ed \u00fa\u010dinky; sni\u017ete d\u00e1vku repaglinidu.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i pokojov\u00e9 teplot\u011b, <strong>pod 25\u00b0C<\/strong>, chr\u00e1n\u011bno p\u0159ed sv\u011btlem a vlhkost\u00ed.<\/li>\n<li>Tablety uchov\u00e1vejte v p\u016fvodn\u00edm blistru a\u017e do pou\u017eit\u00ed.<\/li>\n<li>Neskladujte v koupeln\u011b.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/li>\n<li>Nepou\u017e\u00edvejte po uplynut\u00ed data expirace uveden\u00e9ho na obalu.<\/li>\n<li>Nepou\u017eit\u00e9 tablety vra\u0165te do l\u00e9k\u00e1rny k likvidaci.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy na MedsBase<\/h2>\n<p>Dal\u0161\u00ed l\u00e9ky pou\u017e\u00edvan\u00e9 v protiz\u00e1n\u011btliv\u00e9 a autoimunitn\u00ed p\u00e9\u010di skladem vedle tohoto produktu:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/barinat\/\"><strong>Barinat (baricitinib 2 \/ 4 mg) \u2014 inhibitor JAK1\/2 pro RA<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tofe\/\"><strong>Tofe (tofacitinib 5 mg) \u2014 inhibitor JAK1\/3 pro RA, UC, PsA<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/azoran\/\"><strong>Azoran (azathioprin 50 mg) \u2014 klasick\u00e9 imunosupresivum DMARD<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/conimune-me\/\"><strong>Conimune ME (cyklosporin) \u2014 inhibitor kalcineurinu<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/wysolone\/\"><strong>Wysolone (prednisolon 5 \/ 10 \/ 20 mg) \u2014 peror\u00e1ln\u00ed kortikosteroid<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/medrol\/\"><strong>Medrol (methylprednisolon 4 \/ 8 \/ 16 mg) \u2014 peror\u00e1ln\u00ed kortikosteroid<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/predniheal\/\"><strong>Predniheal (prednisolon) \u2014 peror\u00e1ln\u00ed kortikosteroid<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hisone\/\"><strong>Hisone (hydrokortizon) \u2014 fyziologick\u00e1 n\u00e1hradn\u00ed terapie steroidy<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/budez-cr\/\"><strong>Budez CR (budesonid) \u2014 st\u0159evn\u011b p\u016fsob\u00edc\u00ed kortikosteroid pro Crohnovu chorobu<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/kenacort\/\"><strong>Kenacort (triamcinolon) \u2014 syst\u00e9mov\u00fd kortikosteroid<\/strong><\/a><\/li>\n<\/ul>\n<p>Prozkoumejte celou <a href=\"https:\/\/medsbase.com\/cs\/anti-inflammatory-autoimmune-care\/\">Protiz\u00e1n\u011btliv\u00e1 a autoimunitn\u00ed p\u00e9\u010de<\/a> kategorie.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Jak dlouho trv\u00e1, ne\u017e Lefuheal za\u010dne \u00fa\u010dinkovat?<\/h3>\n<p>Prvn\u00ed zn\u00e1mky zlep\u0161en\u00ed bolesti kloub\u016f se objevuj\u00ed <strong>4\u20136 t\u00fddnech<\/strong>; v\u00fdrazn\u00e9 sn\u00ed\u017een\u00ed otoku a rann\u00ed ztuhlosti obvykle po 6\u201312 t\u00fddnech; pln\u00fd \u00fa\u010dinek na aktivitu onemocn\u011bn\u00ed po <strong>12\u201324 t\u00fddnech<\/strong>. Pomal\u00fd n\u00e1stup \u00fa\u010dinku je jedn\u00edm z n\u00e1ro\u010dn\u011bj\u0161\u00edch aspekt\u016f l\u00e9\u010dby leflunomidem \u2014 mnoho pacient\u016f chce l\u00e9\u010dbu ukon\u010dit po 6 t\u00fddnech, proto\u017ee je\u0161t\u011b nec\u00edt\u00ed benefit. O\u010dek\u00e1v\u00e1n\u00ed mus\u00ed b\u00fdt explicitn\u011b nastaveno na za\u010d\u00e1tku l\u00e9\u010dby.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d mus\u00edme s partnerem pou\u017e\u00edvat antikoncepci p\u0159i u\u017e\u00edv\u00e1n\u00ed Lefuhealu?<\/h3>\n<p>Teriflunomid (aktivn\u00ed metabolit) je siln\u011b teratogenn\u00ed v pokusech na zv\u00ed\u0159atech a pravd\u011bpodobn\u011b i u lid\u00ed \u2014 je klasifikov\u00e1n jako t\u011bhotensk\u00e1 kategorie X. <strong>U pacientek<\/strong> mus\u00ed b\u00fdt po celou dobu l\u00e9\u010dby a nejm\u00e9n\u011b 2 roky po jej\u00edm ukon\u010den\u00ed (nebo dokud cholestyraminov\u00e1 eliminace nepotvrd\u00ed hladinu v plazm\u011b &lt; 0,02 mg\/l ve dvou odd\u011blen\u00fdch vzorc\u00edch s odstupem 14 dn\u016f) pou\u017eita \u00fa\u010dinn\u00e1 antikoncepce. <strong>U pacient\u016f<\/strong> u\u017e\u00edvaj\u00edc\u00edch leflunomid, jejich\u017e partnerka by mohla ot\u011bhotn\u011bt, by m\u011bla b\u00fdt pou\u017eita bari\u00e9rov\u00e1 antikoncepce \u2014 teriflunomid je detekovateln\u00fd v semeni a teoretick\u00e9 riziko pro vyv\u00edjej\u00edc\u00ed se plod je re\u00e1ln\u00e9. Pokud je pl\u00e1nov\u00e1no t\u011bhotenstv\u00ed, je t\u0159eba v\u0161e p\u0159edem napl\u00e1novat a zajistit cholestyraminovou eliminaci P\u0158ED pokusem o po\u010det\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Jak\u00fd je protokol pro cholestyraminovou eliminaci?<\/h3>\n<p>Teriflunomid podl\u00e9h\u00e1 enterohepat\u00e1ln\u00ed recirkulaci, proto p\u0159etrv\u00e1v\u00e1 v plazm\u011b a\u017e 2 roky po ukon\u010den\u00ed l\u00e9\u010dby leflunomidem. <strong>Cholestyramin 8 g t\u0159ikr\u00e1t denn\u011b po dobu 11 dn\u016f<\/strong> v\u00e1\u017ee teriflunomid ve st\u0159ev\u011b, \u010d\u00edm\u017e p\u0159eru\u0161uje recirkula\u010dn\u00ed smy\u010dku a rychle odstra\u0148uje l\u00e9k. Po 11 dnech se zm\u011b\u0159\u00ed hladina teriflunomidu v plazm\u011b; jakmile je &lt; 0,02 mg\/l ve dvou odd\u011blen\u00fdch vzorc\u00edch s odstupem 14 dn\u016f, je eliminace dokon\u010dena. Pou\u017e\u00edv\u00e1 se pro pl\u00e1nov\u00e1n\u00ed t\u011bhotenstv\u00ed, z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, z\u00e1va\u017en\u00e9 infekce nebo rychl\u00fd p\u0159echod na jinou terapii.<\/p>\n<h3 class=\"wp-block-heading\">Budu m\u00edt pr\u016fjem p\u0159i u\u017e\u00edv\u00e1n\u00ed Lefuhealu?<\/h3>\n<p>P\u0159ibli\u017en\u011b 1 z 5 pacient\u016f m\u00e1 klinicky v\u00fdznamn\u00fd pr\u016fjem, obvykle v prvn\u00edch 2\u20133 m\u011bs\u00edc\u00edch. Pom\u00e1haj\u00ed n\u00e1sleduj\u00edc\u00ed strategie: vynechat \u00favodn\u00ed d\u00e1vku, za\u010d\u00edt s 10 mg\/den (a zv\u00fd\u0161it na 20 mg, pokud je tolerov\u00e1no), u\u017e\u00edvat s j\u00eddlem, na\u010dasovat d\u00e1vkov\u00e1n\u00ed podle denn\u00edho re\u017eimu. Pokud pr\u016fjem p\u0159etrv\u00e1v\u00e1 i p\u0159es tato opat\u0159en\u00ed, kr\u00e1tk\u00fd kurz cholestyraminu m\u016f\u017ee rychle odstranit aktivn\u00ed l\u00e9k; revmatolog pak m\u016f\u017ee l\u00e9\u010dbu obnovit s ni\u017e\u0161\u00ed d\u00e1vkou nebo p\u0159ej\u00edt na jin\u00fd DMARD. V\u011bt\u0161ina pacient\u016f, kte\u0159\u00ed sn\u00e1\u0161ej\u00ed prvn\u00ed 1\u20133 t\u00fddny, m\u00e1 dlouhodob\u011b dobr\u00e9 v\u00fdsledky.<\/p>\n<h3 class=\"wp-block-heading\">Vypadnou mi vlasy p\u0159i u\u017e\u00edv\u00e1n\u00ed Lefuhealu?<\/h3>\n<p>M\u00edrn\u00e9 \u0159\u00eddnut\u00ed nebo vypad\u00e1v\u00e1n\u00ed vlas\u016f postihuje asi 10\u201320 % u\u017eivatel\u016f, obvykle za\u010d\u00edn\u00e1 po 2\u20133 m\u011bs\u00edc\u00edch a \u010d\u00e1ste\u010dn\u011b se ust\u00e1l\u00ed. V\u00fdrazn\u00e1 alopecie je neobvykl\u00e1. Ztr\u00e1ta vlas\u016f je po vysazen\u00ed l\u00e9ku pln\u011b reverzibiln\u00ed. Opat\u0159en\u00ed: p\u0159echod na 10 mg\/den, dopl\u0148ky biotinu a zinku, \u0161etrn\u00e1 p\u00e9\u010de o vlasy. Pokud je ztr\u00e1ta vlas\u016f z\u00e1va\u017en\u00e1 a stresuj\u00edc\u00ed, je rozumn\u00e9 probrat s revmatologem mo\u017enost alternativn\u00edho DMARD.<\/p>\n<h3 class=\"wp-block-heading\">Mohu p\u00edt alkohol p\u0159i u\u017e\u00edv\u00e1n\u00ed Lefuhealu?<\/h3>\n<p>Alkohol v\u00fdznamn\u011b zvy\u0161uje riziko hepatotoxicity leflunomidu. V\u011bt\u0161ina revmatolog\u016f doporu\u010duje <strong>ne v\u00edce ne\u017e 1\u20132 alkoholick\u00e9 jednotky t\u00fddn\u011b.<\/strong> na monoterapii leflunomidem, a <strong>\u017e\u00e1dn\u00e9<\/strong> na kombinaci leflunomidu s methotrex\u00e1tem. Pokud jsou jatern\u00ed testy trvale m\u00edrn\u011b zv\u00fd\u0161en\u00e9, m\u011bl by b\u00fdt alkohol zcela vysazen.<\/p>\n<h3 class=\"wp-block-heading\">Jak\u00e9 krevn\u00ed testy pot\u0159ebuji na Lefuheal?<\/h3>\n<p>FBC, jatern\u00ed testy (ALT, AST, ALP, bilirubin) a TK na za\u010d\u00e1tku; pot\u00e9 <strong>m\u011bs\u00ed\u010dn\u011b po dobu 6 m\u011bs\u00edc\u016f<\/strong>; pot\u00e9 <strong>ka\u017ed\u00e9 3 m\u011bs\u00edce<\/strong> na dobu neur\u010ditou. \u010cast\u011bji b\u011bhem obdob\u00ed interkurentn\u00edho onemocn\u011bn\u00ed, konzumace alkoholu nebo zm\u011bny d\u00e1vky. Jak\u00fdkoli vzestup ALT nebo AST &gt; 2\u20133\u00d7 horn\u00ed hranice norm\u00e1lu vyvol\u00e1 p\u0159ezkoum\u00e1n\u00ed p\u0159edepisuj\u00edc\u00edm l\u00e9ka\u0159em a obvykle sn\u00ed\u017een\u00ed d\u00e1vky nebo p\u0159eru\u0161en\u00ed l\u00e9\u010dby. Pokles WCC pod 3,0 \u00d7 10&amp;sup9;\/l nebo trombocyt\u016f pod 100 \u00d7 10&amp;sup9;\/l jsou tak\u00e9 d\u016fvody k ukon\u010den\u00ed l\u00e9\u010dby.<\/p>\n<h3 class=\"wp-block-heading\">Mohu dostat \u017eiv\u00e9 vakc\u00edny na Lefuheal?<\/h3>\n<p>Ne. \u017div\u00e9 vakc\u00edny \u2014 MMR, varicella, \u017elut\u00e1 zimnice, BCG, \u017eiv\u00e1 nosn\u00ed ch\u0159ipka, \u017eiv\u00e1 vakc\u00edna proti p\u00e1sov\u00e9mu oparu Zostavax \u2014 jsou b\u011bhem terapie a po dobu 2 let po jej\u00edm ukon\u010den\u00ed kontraindikov\u00e1ny (nebo dokud cholestyraminov\u00fd v\u00fdplach nepotvrd\u00ed dostate\u010dn\u00e9 vylou\u010den\u00ed). Pokud je to mo\u017en\u00e9, napl\u00e1nujte v\u0161echny \u017eiv\u00e9 vakc\u00edny P\u0158ED zah\u00e1jen\u00edm l\u00e9\u010dby. <strong>Inaktivovan\u00e9 vakc\u00edny<\/strong> \u2014 ka\u017edoro\u010dn\u00ed ch\u0159ipkov\u00e1 vakc\u00edna, pneumokokov\u00e1, COVID-19, rekombinantn\u00ed Shingrix, HPV \u2014 jsou v po\u0159\u00e1dku a doporu\u010duj\u00ed se.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee b\u00fdt Lefuheal pou\u017e\u00edv\u00e1n v kombinaci s biologiky nebo inhibitory JAK?<\/h3>\n<p>Ano \u2014 kombinace leflunomidu s inhibitory TNF (etanercept, adalimumab), abataceptem, rituximabem nebo inhibitory JAK (tofacitinib, baricitinib) je standardn\u00edm revmatologick\u00fdm p\u0159\u00edstupem k rezistentn\u00edmu onemocn\u011bn\u00ed. Kompromisem je vy\u0161\u0161\u00ed riziko z\u00e1va\u017en\u00e9 infekce. Nezbytn\u00fd je odborn\u00fd dohled; profylaxe PCP (ko-trimoxazol) a antivirov\u00e1 profylaxe (aciclovir, valaciclovir) jsou n\u011bkdy p\u0159id\u00e1ny.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Lefuheal je dod\u00e1v\u00e1n v\u00fdrobcem certifikovan\u00fdm WHO-GMP s kompletn\u00ed dokumentac\u00ed COA. Z\u00e1silky odes\u00edl\u00e1me po cel\u00e9m sv\u011bt\u011b v nen\u00e1padn\u00e9m obalu a ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00edm <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>. V\u00e1\u0161 popis transakce p\u0159i platb\u011b kartou zobrazuje regulovan\u00e9ho zpracovatele plateb (regulovan\u00e9ho zpracovatele plateb kartou), nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Dal\u0161\u00ed protiz\u00e1n\u011btliv\u00e9 a autoimunitn\u00ed l\u00e9ky<\/h3>\n<p>Pokud Lefuheal nevyhovuje va\u0161im pot\u0159eb\u00e1m, v t\u00e9to kategorii jsou k dispozici n\u00e1sleduj\u00edc\u00ed alternativy:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/azoran\/\">Azoran (Azathioprin 50 mg, RPG) \u2013 purinov\u00fd antimetabolit<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/conimune-me\/\">Conimune ME (Cyklosporin 25\/50\/100 mg) \u2014 inhibitor kalcineurinu<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/barinat\/\">Barinat (Baricitinib 2\/4 mg, Cipla) \u2013 inhibitor JAK1\/JAK2<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/tofe\/\">Tofe (Tofacitinib 5 mg, Intas) \u2013 pan-JAK inhibitor<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/wysolone\/\">Wysolone (Prednisolon 5\/10\/20 mg) \u2014 p\u0159echodn\u00e9 kortikosteroidy<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 L\u00e9\u010d\u00ed revmatoidn\u00ed artritidu<br \/>\n\u2705 Sni\u017euje z\u00e1n\u011bt kloub\u016f<br \/>\n\u2705 Zpomaluje progresi onemocn\u011bn\u00ed<br \/>\n\u2705 Zlep\u0161uje funkci kloub\u016f<br \/>\n\u2705 Obsahuje Leflunomid<\/p>\n<p>Lefuheal obsahuje Leflunomid.<\/p>","protected":false},"featured_media":57923,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3897,3141,3223],"product_tag":[4385,4386],"class_list":{"0":"post-57922","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-inflammatory-autoimmune-care","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-leflunomide","10":"product_tag-lefuheal","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/57922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=57922"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/57923"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=57922"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=57922"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=57922"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=57922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}